Use of Immersive Virtual Reality to Train the Multisensory Processing Capacities of Children Aged 8 to 16 Years-old With an Autism Spectrum Disorder: Single-center Randomized Pilot Study in Parallel Groups - SEVIRE. (Sensory Virtual Reality)

Recruiting now · Not applicable

Conditions studied: Autism Spectrum Disorder

In brief

Autism Spectrum Disorder (ASD) is defined as a neurodevelopmental disorder that affects the functioning and development of social communication (DSM5 - 2013). ASD causes particularities in sensory treatments (auditory, visual), qualified as uni-modal. Added to this, there is difficulties to deal with prevailing stimuli of the environment (pluri-modal) ; parents report the discomfort of their child in this situation with "noisy" behavioral manifestations. Therapeutic social skills programs most often address the subject's lack of adjustment to their environment through understanding social rules and codes and cognitive treatment of situations. Thus, in order to relieve the sensory modulation disorders which can be the cause of social adjustment difficulties, it's propose to exercise the sensory habituation of children with ASD thanks to virtual reality scenarios restored in 3D immersion booth (the CAVE). The child will be exposed to multimodal stimulation during immersion sessions reproducing the conditions of an ecological environment. A therapist will accompany the child in the CAVE throughout the session. The investigators hypothesize that regular and repeated exposure to a simulated environment in the CAVE can improve multisensory treatment capacities and have a beneficial effect on the autonomy of children and adolescents with ASD in everyday situations.

Key facts

Study ID: NCT05171244
Run by: University Hospital, Tours
People needed: 50
Starts: 2022-03-03
Expected to finish: 2028-08-01
Last updated by the study team: 2026-06-11

Who can join

Age: 8 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Child / adolescent aged 8 to 16 years, diagnosed with ASD (DSM-5, ADOS, ADI-R criteria).
Without intellectual delay (QNV> 70, WISC-IV or V, WAIS-III or IV).
Benefiting from a treatment program at the University Center for Child Psychiatry (CHRU Bretonneau-Tours).
Schooled in the ordinary school context (primary school, middle school, high school, ULIS).
Having expressed their agreement to participate in the study.
Whose parents or legal representatives have signed written consent.
Whose parents or legal representatives are affiliated or beneficiaries of a social security scheme.

You may not qualify if…

Neuromotor disorders.
Uncorrected visual disorders.
Hearing impairment.
Known epilepsy.
Anxiety syndromes identified.
Hyper ADD / H type activity.
Treatment with methylphenidate. - Rare genetic syndrome.

Where it is running

Le Centre universitaire de pédopsychiatrie — Tours, Tours, France (enrolling)
Pedopsychiatry, University Hospital, Tours — Tours, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.